MA35439B1 - Inhibiteurs de l'enzyme activant nedd8 - Google Patents
Inhibiteurs de l'enzyme activant nedd8Info
- Publication number
- MA35439B1 MA35439B1 MA36826A MA36826A MA35439B1 MA 35439 B1 MA35439 B1 MA 35439B1 MA 36826 A MA36826 A MA 36826A MA 36826 A MA36826 A MA 36826A MA 35439 B1 MA35439 B1 MA 35439B1
- Authority
- MA
- Morocco
- Prior art keywords
- nedd8
- inhibitors
- activating enzyme
- activating
- enzyme
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526830P | 2011-08-24 | 2011-08-24 | |
| PCT/US2012/052007 WO2013028832A2 (fr) | 2011-08-24 | 2012-08-23 | Inhibiteurs de l'enzyme activant nedd8 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA35439B1 true MA35439B1 (fr) | 2014-09-01 |
Family
ID=47747080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA36826A MA35439B1 (fr) | 2011-08-24 | 2014-03-13 | Inhibiteurs de l'enzyme activant nedd8 |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US8809356B2 (fr) |
| EP (2) | EP3323414A1 (fr) |
| JP (1) | JP6038150B2 (fr) |
| KR (1) | KR20140054288A (fr) |
| CN (1) | CN103889988B (fr) |
| AR (1) | AR087672A1 (fr) |
| AU (1) | AU2012298813B2 (fr) |
| BR (1) | BR112014004239A2 (fr) |
| CA (1) | CA2846231C (fr) |
| CL (1) | CL2014000441A1 (fr) |
| CO (1) | CO6900148A2 (fr) |
| CR (1) | CR20140128A (fr) |
| DO (1) | DOP2014000037A (fr) |
| EA (1) | EA031067B1 (fr) |
| EC (1) | ECSP14013263A (fr) |
| GE (1) | GEP201606522B (fr) |
| HK (1) | HK1199252A1 (fr) |
| IL (1) | IL231069B (fr) |
| MA (1) | MA35439B1 (fr) |
| MX (1) | MX2014002015A (fr) |
| MY (1) | MY166889A (fr) |
| PE (1) | PE20141146A1 (fr) |
| SG (2) | SG11201400102WA (fr) |
| TN (1) | TN2014000080A1 (fr) |
| TW (1) | TWI577667B (fr) |
| UA (1) | UA114894C2 (fr) |
| UY (1) | UY34292A (fr) |
| WO (1) | WO2013028832A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| CN103889988B (zh) * | 2011-08-24 | 2018-05-04 | 米伦纽姆医药公司 | Nedd8-活化酶的抑制剂 |
| US9290500B2 (en) | 2012-02-17 | 2016-03-22 | Millennium Pharmaceuticals, Inc. | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme |
| WO2014022744A1 (fr) | 2012-08-03 | 2014-02-06 | Millennium Pharmaceuticals, Inc. | Inhibiteurs de pyrrolopyrimidinyle substitué par indole d'uba6 |
| EP2764866A1 (fr) | 2013-02-07 | 2014-08-13 | IP Gesellschaft für Management mbH | Inhibiteurs de l'enzyme activant nedd8 |
| EA032577B1 (ru) * | 2013-07-02 | 2019-06-28 | Милленниум Фармасьютикалз, Инк. | Гетероарильные соединения, пригодные в качестве ингибиторов sumo-активирующего фермента |
| CN103948590A (zh) * | 2014-05-22 | 2014-07-30 | 中国药科大学 | Nedd8激活酶抑制剂及其医药用途 |
| UA122963C2 (uk) | 2014-07-01 | 2021-01-27 | Мілленніум Фармасьютікалз, Інк. | Гетероарильні сполуки, придатні як інгібітори sumo-активуючого ферменту |
| WO2017183927A1 (fr) * | 2016-04-20 | 2017-10-26 | 한국화학연구원 | Nouveau composé hétérocyclique, procédé de préparation de celui-ci et composition pharmaceutique contenant celui-ci en tant que principe actif pour la prévention ou le traitement du cancer |
| WO2018213258A1 (fr) * | 2017-05-15 | 2018-11-22 | Millennium Pharmaceuticals, Inc. | Traitement de tumeurs déficientes en merlin à l'aide d'inhibiteurs de nae |
| WO2023025668A1 (fr) | 2021-08-25 | 2023-03-02 | Asociación Centro De Investigación Cooperativa En Biociencias-Cic Biogune | Méthodes pour la génération de lymphocytes t à mémoire de cellules souches pour une thérapie adoptive par lymphocytes t |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5194446A (en) | 1989-06-12 | 1993-03-16 | A. H. Robins Company, Incorporated | Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
| WO1997005132A1 (fr) | 1995-07-28 | 1997-02-13 | Cubist Pharmaceuticals, Inc. | Analogues de l'adenylate d'aminoacyle en tant qu'agents antimicrobiens et antiparasites nouveaux |
| AU2003291024A1 (en) | 2002-11-13 | 2004-06-03 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| EP1680431A1 (fr) | 2003-10-17 | 2006-07-19 | Rigel Pharmaceuticals, Inc. | Compositions de benzothiazole et de thiazole'5,5-b!pyridine et leur utilisation comme inhibiteurs de l'ubiquitine ligase |
| US20050282818A1 (en) | 2004-06-22 | 2005-12-22 | Rigel Pharmaceuticals, Inc. | Ubiquitin ligase inhibitors |
| SI1848718T1 (sl) | 2005-02-04 | 2012-12-31 | Millennium Pharmaceuticals, Inc. | Inhibitorji E1 aktivacijskih enzimov |
| EP1989206B1 (fr) | 2006-02-02 | 2012-07-04 | Millennium Pharmaceuticals, Inc. | Inhibiteurs d'enzyme d'activation e1 |
| MY157177A (en) * | 2006-08-08 | 2016-05-13 | Millennium Pharm Inc | Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| US8008307B2 (en) | 2006-08-08 | 2011-08-30 | Millennium Pharmaceuticals, Inc. | Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| PE20120907A1 (es) * | 2009-05-14 | 2012-08-18 | Millennium Pharm Inc | Sal de clorhidrato de ((1s,2s,4r)-4-{4-[(1s)-2,3-dihidro-1h-inden-1-ilamino]-7h-pirrolo[2,3-d]pirimidin-7-il}-2-hidroxiciclopentil)metilsulfamato |
| CN103889988B (zh) * | 2011-08-24 | 2018-05-04 | 米伦纽姆医药公司 | Nedd8-活化酶的抑制剂 |
| UA114414C2 (uk) * | 2011-11-03 | 2017-06-12 | Мілленніум Фармасьютікалз, Інк. | Введення інгібітору ферменту, що активує nedd8, і гіпометилуючого засобу |
-
2012
- 2012-08-23 CN CN201280052013.2A patent/CN103889988B/zh not_active Expired - Fee Related
- 2012-08-23 MX MX2014002015A patent/MX2014002015A/es unknown
- 2012-08-23 EA EA201400249A patent/EA031067B1/ru not_active IP Right Cessation
- 2012-08-23 JP JP2014527287A patent/JP6038150B2/ja not_active Expired - Fee Related
- 2012-08-23 AU AU2012298813A patent/AU2012298813B2/en not_active Ceased
- 2012-08-23 EP EP17193006.8A patent/EP3323414A1/fr not_active Withdrawn
- 2012-08-23 SG SG11201400102WA patent/SG11201400102WA/en unknown
- 2012-08-23 PE PE2014000250A patent/PE20141146A1/es active IP Right Grant
- 2012-08-23 SG SG10201601023UA patent/SG10201601023UA/en unknown
- 2012-08-23 MY MYPI2014000482A patent/MY166889A/en unknown
- 2012-08-23 GE GEAP201213424A patent/GEP201606522B/en unknown
- 2012-08-23 WO PCT/US2012/052007 patent/WO2013028832A2/fr active Application Filing
- 2012-08-23 BR BR112014004239A patent/BR112014004239A2/pt not_active Application Discontinuation
- 2012-08-23 CA CA2846231A patent/CA2846231C/fr not_active Expired - Fee Related
- 2012-08-23 US US13/592,389 patent/US8809356B2/en active Active
- 2012-08-23 KR KR1020147007200A patent/KR20140054288A/ko active IP Right Grant
- 2012-08-23 UA UAA201402893A patent/UA114894C2/uk unknown
- 2012-08-23 EP EP12825411.7A patent/EP2748168A4/fr not_active Withdrawn
- 2012-08-24 UY UY0001034292A patent/UY34292A/es not_active Application Discontinuation
- 2012-08-24 TW TW101130884A patent/TWI577667B/zh not_active IP Right Cessation
- 2012-08-24 AR ARP120103134A patent/AR087672A1/es unknown
-
2014
- 2014-02-20 IL IL231069A patent/IL231069B/en active IP Right Grant
- 2014-02-21 TN TNP2014000080A patent/TN2014000080A1/en unknown
- 2014-02-24 CL CL2014000441A patent/CL2014000441A1/es unknown
- 2014-02-24 DO DO2014000037A patent/DOP2014000037A/es unknown
- 2014-03-12 CO CO14052377A patent/CO6900148A2/es unknown
- 2014-03-13 MA MA36826A patent/MA35439B1/fr unknown
- 2014-03-17 CR CR20140128A patent/CR20140128A/es unknown
- 2014-03-21 EC ECSP14013263 patent/ECSP14013263A/es unknown
- 2014-07-08 US US14/326,051 patent/US9850214B2/en active Active
- 2014-12-22 HK HK14112794.7A patent/HK1199252A1/xx unknown
-
2017
- 2017-11-09 US US15/808,491 patent/US20180290983A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2023023I1 (el) | Παραγωγα λακταμης χρησιμα ως αναστολεις μεταλλαγμενης idh1 | |
| FR23C1023I2 (fr) | Anticorps anti-il-36r | |
| MA35439B1 (fr) | Inhibiteurs de l'enzyme activant nedd8 | |
| SMT201600108B (it) | Derivato di pirazochinolina come inibitori di pde9 | |
| SMT201600135B (it) | Nuovi inibitori della s-nitrosoglutatione riduttasi | |
| HK1200190A1 (en) | Targeted enzyme compounds and uses thereof | |
| HK1204477A1 (en) | Single domain antibodies as inhibitors of pcsk9 pcsk9 | |
| CR20120576A (es) | Inhibidores de pirazolil quinazolina cinasa | |
| CO7010824A2 (es) | Inhibidores de aplicación viral | |
| CO6781493A2 (es) | Inhibidores de la faah | |
| BR112015000507A2 (pt) | inibição de enzimas | |
| IL230561A0 (en) | Broton tyrosine kinase inhibitors | |
| BR112013025761A2 (pt) | inibidores de hsp90 | |
| BR112014013850A2 (pt) | conjunto de prateleiras | |
| BR112014000022A2 (pt) | 1-3-tiazepinas ciclopropil-fundidas como inibidores de bace 1 e/ou bace 2 | |
| BR302012001179S1 (pt) | "configuração aplicada em farol" | |
| BR302012001168S1 (pt) | "configuração aplicada em farol" | |
| CO6852074A2 (es) | Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida | |
| CO6990727A2 (es) | Derivados de quinolina como inhibidores de la enzima pde10a | |
| BR112012029363A2 (pt) | 'método para produção de 1-alquil-3-difluormetil-5-hidroxipirazóis' | |
| ITUD20120163A1 (it) | "articolo di abbigliamento intimo" | |
| IT1399731B1 (it) | Procedimento per la realizzazione di monili | |
| UA22548S (uk) | Міст керований | |
| UA22262S (uk) | Орденський знак | |
| UA23028S (uk) | Комплект прикрас до пляшки |